The acquisition will aim to build on OPEN Health’s leading service offerings
Astorg and Amulet Capital Partners have announced the signing of a binding agreement, through which Astorg will acquire OPEN Health. Astorg will actively support and accelerate OPEN Health’s next phase of growth and innovation.
OPEN Health is a leading global provider of scientific communications and market access services to the pharmaceutical industry, established in 2011. The platform is a key partner to its customers in helping them to develop strategies for evidence generation and data communication.
OPEN Health has over 1,000 employees in 15 locations and six countries, across North America, Europe, and Asia.
“We are excited to build on the momentum across our business and to continue executing with our new partners at Astorg on a shared long-term vision to bring deep scientific solutions that support our clients in driving positive health outcomes,” said Rob Barker, CEO, OPEN Health. “We are grateful for the strong partnership of the Amulet team over the last three and a half years, and for all that we have accomplished in expanding our industryleading capabilities across disciplines. We continue to be very well positioned to drive innovation and growth, and we look forward to embarking on this next chapter for OPEN Health.”
Astorg will aim to build upon OPEN Health’s leading service offerings, investing in the development of the business across its main existing offerings and beyond.
Ramsey Frank, President and Managing Partner of Amulet, said, “OPEN Health was built around Amulet’s investment thesis in medical affairs: the current generation of drugs is fundamentally different from prior generations, and these therapies need to be brought to market with the support of high science communications and data analytics. We brought OPEN Health together very intentionally, via three acquisitions, to create a purpose-built suite of services to meet pharma’s evolving needs.”
Pharmaceutical Industry news, analysis and insights